Skip to main content
Jennifer (Ko) Jao, MD, Infectious Disease, Chicago, IL

Jennifer(Ko)JaoMD

Infectious Disease Chicago, IL

HIV/AIDS Medicine

Assistant Professor, Medicine, Icahn School of Medicine

Dr. Jao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jao's full profile

Already have an account?

  • Office

    225 E Chicago Ave
    # 20
    Chicago, IL 60611
    Phone+1 312-227-4080
    Fax+1 312-227-9709

Education & Training

  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineMPH, Epidemiology, 2008 - 2010
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 2007 - 2009
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine/Pediatrics, 1998 - 2002
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 1998

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1998 - 2026
  • NY State Medical License
    NY State Medical License 2005 - 2020
  • NJ State Medical License
    NJ State Medical License 2005 - 2009
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Perinatal HIV Nearly Eradicated in U.S.
    Perinatal HIV Nearly Eradicated in U.S.April 18th, 2023
  • Study Finds Rise in Marijuana Use Among Pregnant and Postpartum People Living with HIV
    Study Finds Rise in Marijuana Use Among Pregnant and Postpartum People Living with HIVJanuary 4th, 2022
  • Dolutegravir-Based Antiretroviral Therapies for HIV-1 Effective in Pregnancy
    Dolutegravir-Based Antiretroviral Therapies for HIV-1 Effective in PregnancySeptember 9th, 2022
  • Join now to see all

Professional Memberships